GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicine Man Technologies Inc (NEOE:SHWZ) » Definitions » EV-to-EBIT

Medicine Man Technologies (NEOE:SHWZ) EV-to-EBIT : -23.64 (As of Nov. 10, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Medicine Man Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medicine Man Technologies's Enterprise Value is C$269.9 Mil. Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was C$-11.4 Mil. Therefore, Medicine Man Technologies's EV-to-EBIT for today is -23.64.

The historical rank and industry rank for Medicine Man Technologies's EV-to-EBIT or its related term are showing as below:

NEOE:SHWZ' s EV-to-EBIT Range Over the Past 10 Years
Min: -474.96   Med: -4.72   Max: 940.53
Current: -22.62

During the past 10 years, the highest EV-to-EBIT of Medicine Man Technologies was 940.53. The lowest was -474.96. And the median was -4.72.

NEOE:SHWZ's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.33 vs NEOE:SHWZ: -22.62

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medicine Man Technologies's Enterprise Value for the quarter that ended in Jun. 2024 was C$297.2 Mil. Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was C$-11.4 Mil. Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -3.84%.


Medicine Man Technologies EV-to-EBIT Historical Data

The historical data trend for Medicine Man Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicine Man Technologies EV-to-EBIT Chart

Medicine Man Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.08 -4.10 3.04 7.04 12.59

Medicine Man Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.12 12.88 12.59 -377.05 -25.41

Competitive Comparison of Medicine Man Technologies's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Medicine Man Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicine Man Technologies's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicine Man Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medicine Man Technologies's EV-to-EBIT falls into.



Medicine Man Technologies EV-to-EBIT Calculation

Medicine Man Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=269.919/-11.416
=-23.64

Medicine Man Technologies's current Enterprise Value is C$269.9 Mil.
Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicine Man Technologies  (NEOE:SHWZ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medicine Man Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-11.416/297.171617
=-3.84 %

Medicine Man Technologies's Enterprise Value for the quarter that ended in Jun. 2024 was C$297.2 Mil.
Medicine Man Technologies's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicine Man Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medicine Man Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicine Man Technologies Business Description

Traded in Other Exchanges
Address
865 N. Albion Street, Suite 300, Denver, CO, USA, 80220
Medicine Man Technologies Inc is a vertically integrated multi-state cannabis operator focused on growth through expansion into existing and new markets. The Company's business involves the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis-related products. The Company sells products it manufactures and cultivates and a variety of other cannabis goods through wholly-owned retail stores, licensing arrangements, and/or third-party operators and retailers. Its operations are organized into three different segments: Retail, consisting of retail locations for sale of cannabis products; Wholesale, consisting of manufacturing, cultivation, and sale of both wholesale cannabis and non-cannabis products; and Other, consisting of all other income and expenses.